The health regulator flagged application deficiencies related to the FDA’s pre-license inspection of the company’s third-party contract manufacturing firms.
Tag Archive for: ImmunityBio
Ten months after taking over a state-of-the-art facility in New York that was expected to expand the company’s manufacturing footprint, ImmunityBio announced job cuts at the site.
